Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian
The best Android phones in 2025 : flagship smartphones compared and ranked
31/10/2025
After a zeitgeisty Halloween costume ? Look no further than the back of your wardrobe
30/10/2025
How do I break up with a kind and generous man who leaves me feeling cold and irritated ? | Leading questions
30/10/2025
Should my boyfriend wear the clothes I buy for him ?
30/10/2025
Jess Cartner-Morley : this season, your jeans should be stiff, smart and straight
29/10/2025
Give me shelter : protecting trafficked children in the US - documentary
23/10/2025